Abstract
Nanotechnology can be defined as the design, creation, and manipulation of structures on the nanometer scale. This two-part review is intended to acquaint the interventionalist with the field of nanotechnology, and provide an overview of potential applications, while highlighting advances relevant to interventional radiology. Part 2 of the article concentrates on drug delivery, thermotherapy, and vascular intervention. In oncology, advances in drug delivery allow for improved efficacy, decreased toxicity, and greater potential for targeted therapy. Magnetic nanoparticles show potential for use in thermotherapy treatments of various tumours, and the effectiveness of radiofrequency ablation can be enhanced with nanoparticle chemotherapy agents. In vascular intervention, much work is focused on prevention of restenosis through developments in stent technology and systems for localised drug delivery to vessel walls. Further areas of interest include applications for thrombolysis and haemostasis.
Similar content being viewed by others
References
Haley B, Frenkel E (2008) Nanoparticles for drug delivery in cancer treatment. Urol Oncol 26:57–64
Farokhzad OC, Langer R (2006) Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 58:1456–1459
Bangham AD, Standish MM, Watkins JC (1965) Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13:238–252
Tomalia DA, Reyna LA, Svenson S (2007) Dendrimers as multi-purpose nanodevices for oncology drug delivery and diagnostic imaging. Biochem Soc Trans 35:61–67
Shukla R, Thomas TP, Peters JL et al (2006) HER2 specific tumor targeting with dendrimer conjugated Anti-HER2 mAb. Bioconjug Chem 17:1109–1115
Uwatoku T, Shimokawa H, Abe K et al (2003) Application of nanoparticle technology for the prevention of restenosis after balloon injury in rats. Circ Res 92:e62–e69
Jin C, Bai L, Wu H et al (2007) Radiosensitization of paclitaxel, etanidazole, and paclitaxel + etanidazole nanoparticles on hypoxic human tumour cells in vitro. Biomaterials 28:3724–3730
Li X, Li R, Qian X et al (2008) Superior antitumor efficiency of cisplatin-loaded nanoparticles by intratumoral delivery with decreased tumor metabolism rate. Eur J Pharm Biopharm 70:726–734
Krishnadas A, Rubinstein I, Onyüksel H (2003) Sterically stabilized phospholipid mixed micelles: in vitro evaluation as a novel carrier for water-insoluble drugs. Pharm Res 20:297–302
Thrall JH (2004) Nanotechnology and medicine. Radiology 230:315–318
Gordon R, Losic D, Tiffany MA et al (2009) The glass menagerie: diatoms for novel applications in nanotechnology. Trends Biotechnol 27:116–127
Chertok B, Moffat BA, David AE et al (2008) Iron oxide nanoparticles as a drug delivery vehicle for MRI monitored magnetic targeting of brain tumours. Biomaterials 29:487–496
Son SJ, Reichel J, He B et al (2005) Magnetic nanotubes for magnetic-field-assisted bioseparation, biointeraction, and drug delivery. J Am Chem Soc 127:7316–7317
Brigger I, Dubernet C, Couvreur P (2002) Nanoparticles in cancer therapy and diagnosis. Adv Drug Deliv Rev 54:631–651
Alexis F, Rhee J, Richie JP et al (2008) New frontiers in nanotechnology for cancer treatment. Urol Oncol 26:74–85
Heath JR, Davis ME (2008) Nanotechnology and cancer. Annu Rev Med 59:251–265
Couvreur P, Vauthier C (2006) Nanotechnology: intelligent design to treat complex disease. Pharm Res 23:1417–1450
Kim S, Lim YT, Soltesz EG et al (2004) Near-infrared fluorescent type II quantum dots for sentinel lymph node mapping. Nat Biotechnol 22:93–97
Pope-Harmon A, Cheng MM, Robertson F et al (2007) Biomedical nanotechnology for cancer. Med Clin North Am 91:899–927
Nie S, Y. X, Kim GJ, et al. (2007) Nanotechnology applications in cancer. Annu Rev Biomed Eng 9:257–288
Koo YL, Reddy GR, Bhojani M et al (2006) Brain cancer diagnosis and therapy with nanoplatforms. Adv Drug Deliv Rev 58:1556–1577
Kim KY (2007) Nanotechnology platforms and physiological challenges for cancer therapeutics. Nanomedicine 3:103–110
Koo OM, Rubinstein I, Onyuksel H (2005) Role of nanotechnology in targeted drug delivery and imaging: a concise review. Nanomedicine 1:193–212
Harries M, Ellis P, Harper P (2005) Nanoparticle albumin-bound paclitaxel for metastatic breast cancer. J Clin Oncol 23:7768–7771
Damascelli B, Patelli G, Tichá V et al (2007) Feasibility and efficacy of percutaneous transcatheter intrarterial chemotherapy with paclitaxel in albumin nanoparticles for advanced squamous-cell carcinoma of the oral cavity, oropharynx, and hypopharynx. J Vasc Interv Radiol 18:1395–1403
Na K, Bae YH (2002) Self-Assembled hydrogel nanoparticles responsive to tumor extracellular ph from pullulan derivative/sulfonamide conjugate: characterization, aggregation, and adriamycin release in vitro. Pharm Res 19:681–688
Reddy GR, Bhojani MS, McConville P et al (2006) Vascular targeted nanoparticles for imaging and treatment of brain tumours. Clin Cancer Res 12:6677–6686
Soma CE, Dubernet C, Bentolila D et al (2000) Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles. Biomaterials 21:1–7
Nakano K, Egashira K, Masuda S et al (2009) Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries. JACC: Cardiovasc Interv 2:277–283
Matsumura Y, Maeda H (1986) A New concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accummulation of proteins and the antitumour agents Smancs. Cancer Res 46:6387–6392
Maeda H, Wu J, Sawa T et al (2000) Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Control Release 65(1–2):271–284
Mu L, Feng SS (2003) A novel controlled release formulation for the anticancer drug paclitaxel (Taxol): PLGA nanoparticles containing vitamin E TPGS. J Control Release 86:33–48
Damascelli B, Cantù G, Mattavelli F et al (2001) Intraarterial chemotherapy with polyoxyethylated castor oil free paclitaxel, incorporated in albumin nanoparticles (ABI-007): phase II study of patients with squamous cell carcinoma of the head and neck and anal canal: preliminary evidence of clinical activity. Cancer 92:2592–2602
Zhou J, Leuschner C, Kumar C et al (2006) Sub-cellular accummulation of magnetic nanoparticles in breast tumors and metastases. Biomaterials 27:2001–2008
Thorek DLJ, Chen AK, Czupryna J et al (2006) Superparamagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 34:23–38
Moore A, Marecos E, Bogdanov A et al (2000) Tumoral distribution of long-circulating dextran-coated iron oxide nanoparticles in a rodent model. Radiology 214:568–574
Barraud L, Merle P, Soma E et al (2005) Increase of doxorubicin sensitivity by doxorubicin-loading into nanoparticles for hepatocellular carcinoma cells in vitro and in vivo. J Hepatol 42:736–743
Storm G, Belliot SO, Daemen T et al (1995) Surface modification of nanoparticles to oppose uptake by the mononuclear phagocyte system. Adv Drug Deliv Rev 17:31–48
Gabizon A, Catane R, Uziely B et al (1994) Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 54:987–992
Sahoo SK, Ma W, Labhasetwar V (2004) Efficacy of transferrin-conjugated paclitaxel-loaded nanoparticles in a murine model of prostate cancer. Int J Cancer 112:335–340
Leamon CP, Reddy JA (2004) Folate-targeted chemotherapy. Adv Drug Deliv Rev 56:1127–1141
Tokumitsu H, Hiratsuka J, Sakurai Y et al (2000) Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor. Cancer Lett 150:177–182
Lesinski GB, Sharma S, Varker KA et al (2005) Release of biologically functional interferon-alpha from a nanochannel delivery system. Biomed Microdevices 7:71–79
Damascelli B, Patelli GL, Lanocita R et al (2003) A novel intraarterial chemotherapy using paclitaxel in albumin nanoparticles to treat advanced squamous cell carcinoma of the tongue: preliminary findings. AJR Am J Roentgenol 181:253–260
Nobuto H, Sugita T, Kubo T et al (2004) Evaluation of systemic chemotherapy with magnetic liposomal doxorubicin and a dipole external electromagnet. Int J Cancer 109:627–635
Lemke AJ, Senfft von Pilsach MI, Lübbe A et al (2004) MRI after magnetic drug targeting in patients with advanced solid malignant tumours. Eur Radiol 14:1949–1955
Avilés MO, Ebner AD, Ritter JA (2009) In vitro study of magnetic particle seeding for implant-assisted magnetic drug targeting: seed and magnetic drug carrier particle capture. J Magn Magn Mater 321:1586–1590
Luciani A, Wilhelm C, Bruneval P et al (2009) Magnetic targeting of iron-oxide-labeled fluorescent hepatoma cells to the liver. Eur Radiol 19:1087–1096
Mahmood U (2004) Can MR imaging be used to track delivery of intravascularly administered stem cells. Radiology 233:625–626
Dick AJ, Guttman MA, Raman VK et al (2003) Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in swine. Circulation 108:2899–2904
Bulte JW, Douglas T, Witwer B et al (2001) Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells. Nat Biotechnol 19:1141–1147
Rice HE, Hsu EW, Sheng H et al (2007) Superparamagnetic iron oxide labeling and transplantation of adipose-derived stem cells in middle cerebral artery occlusion-injured mice. AJR Am J Roentgenol 188:1101–1108
Bos C, Delmas Y, Desmoulière A et al (2004) In vivo MR imaging of intravascularly injected magnetically labeled mesenchymal stem cells in rat kidney and liver. Radiology 233:781–789
Husseini GA, Pitt WG (2008) Micelles and nanoparticles for ultrasonic drug and gene delivery. Adv Drug Deliv Rev 60:1137–1152
Ferrara KW (2008) Driving delivery vehicles with ultrasound. Adv Drug Deliv Rev 60:1097–1102
Rapoport N, Gao Z, Kennedy A (2007) Multifunctional nanoparticles for combining ultrasonic tumor imaging and targeted chemotherapy. J Natl Cancer Inst 99:1095–1106
Dayton PA, Zhao S, Bloch SH et al (2006) Application of ultrasound to selectively localize nanodroplets for targeted imaging and therapy. Mol Imaging 5:160–174
Nelson JL, Roeder BL, Carmen JC et al (2002) Ultrasonically activated chemotherapeutic drug delivery in a rat model. Cancer Res 62:7280–7283
Myhr G, Moan J (2006) Synergistic and tumour selective effects of chemotherapy and ultrasound treatment. Cancer Lett 232:206–213
Gao Z, Fain HD, Rapoport N (2005) Controlled and targeted tumor chemotherapy by micellar-encapusulated drug and ultrasound. J Control Release 102:203–222
Pison U, Welte T, Giersig M et al (2006) Nanomedicine for respiratory disease. Eur J Pharmacol 533(1–3):341–350
Azarmi S, Roa WH, Lobenberg R (2008) Targeted delivery of nanoparticles for the treatment of lung diseases. Adv Drug Deliv Rev 60:863–875
Marsh JN, Senpan A, Hu G et al (2007) Fibrin-targeted perfluorocarbon nanoparticles for targeted thrombolysis. Nanomedicine 2:533–543
Lanza G, Winter P, Cyrus T et al (2006) Nanomedicine opportunities in cardiology. Ann N Y Acad Sci 1080:451–465
Gerwin N, Hops C, Lucke A (2006) Intraarticular drug delivery in osteoarthritis. Adv Drug Deliv Rev 58:226–242
Mountziaris PM, Kramer PR, Mikos AG (2009) Emerging intra-articular drug delivery systems for the temporomandibular joint. Methods 47:134–140
Horisawa E, Hirota T, Kawazoe S et al (2002) Prolonged anti-inflammatory action of DL-lactide/glycolide copolymer nanospheres containing betamethasone sodium phosphate for an intra-articular delivery system in antigen-induced arthritic rabbit. Pharm Res 19:403–410
Raman JD, Hall DW, Cadeddu JA (2009) Renal ablative therapy: radiofrequency ablation and cryoablation. J Surg Oncol 100:639–644
O’Neal DP, Hirsch LR, Halas NJ et al (2004) Photo-thermal tumor ablation in mice using near infrared-absorbing nanoparticles. Cancer Lett 209:171–176
Hildebrandt B, Wust P, Ahlers O et al (2002) The cellular and molecular basis of hyperthermia. Crit Rev Oncol Hematol 43:33–56
Hilger I, Hergt R, Kaiser WA (2005) Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc Nanobiotechnol 152:33–39
Johannsen M, Gneveckow U, Taymoorian K et al (2007) Thermal therapy of prostate cancer using magnetic nanoparticles. Actas Urol Esp 31:660–667
Takamatsu S, Matsui O, Gabata T et al (2008) Selective induction hyperthermia following transcatheter arterial embolization with a mixture of nano-sized magnetic particles (ferucarbotran) and embolic materials: feasibility study in rabbits. Radiat Med 26:179–187
Johannsen M, Gneveckow U, Thiesen B et al (2007) Thermotherapy of prostate cancer using magnetic nanoparticles: feasibility, imaging, and three dimensional temperature distribution. Eur Urol 52:1653–1661
Hilger I, Andrä W, Hergt R et al (2001) Electromagnetic heating of breast tumours in interventional radiology: in vitro and in vivo studies in human cadavers and mice. Radiology 218:570–575
Ahmed M, Monsky WE, Girnun G et al (2003) Radiofrequency thermal ablation sharply increases intratumoural liposomal doxorubicin accummulation and tumor coagulation. Cancer Res 63:6327–6333
Goldberg SN, Girnan GD, Lukyanov AN et al (2002) Percutaneous tumor ablation: increased necrosis with combined radiofrequency ablation and intravenous liposomal doxorubicin in a rat breast tumour model. Radiology 222:797–804
Goldberg SN, Kamel IR, Kruskal JB et al (2002) Radiofrequency ablation of hepatic tumours: increased tumour destruction with adjuvant liposomal doxorubicin therapy. AJR Am J Roentgenol 179:93–101
Ahmed M, Liu Z, Lukyanov AN et al (2005) Combination radiofrequency ablation with intratumoral liposomal doxorubicin: effect on drug accummulation and coagulation in multiple tissues and tumor types in animals. Radiology 235:469–477
Ahmed M, Lukyanov AN, Torchilin V et al (2005) Combined radiofrequency ablation and adjuvant liposomal chemotherapy: effect of chemotherapeutic agent, nanoparticle size, and circulation time. J Vasc Interv Radiol 16:1365–1371
Kong DF, Goldschmidt-Clermont PJ (2005) Tiny solutions for giant cardiac problems. Trends Cardiovasc Med 15:207–211
Stone GW, Ellis SG, Cox DA et al (2004) A polymer-based paclitaxel-eluting stent in patients with coronary artery disease. N Engl J Med 350:221–231
Babapulle MN, Joseph L, Bélisle P et al (2004) A hierarchical bayesian meta-analysis of randomised clinical trials of drug-eluting stents. Lancet 364(9434):583–591
Stone GW, Ellis SG, Cox DA et al (2004) One-year clinical results with the slow-release, polymer based, paclitaxel-eluting TAXUS stent. The TAXUS-IV trial. Circulation 109:1942–1947
Lansky AJ, Costa RA, Mintz GS et al (2004) Non-polymer-based paclitaxel-coated coronary stents for the treatment of pateints with de novo coronary lesions. Angiographic follow-up of the DELIVER clinical trial. Circulation 109:1948–1954
Virmani R, Liistro F, Stankovic G et al (2002) Mechanism of late in-stent restenosis after implantation of a paclitaxel derivative-eluting polymer stent system in humans. Circulation 106:2649–2651
Laskey WK, Yancy CW, Maisel WH (2007) Thrombosis in coronary drug-eluting stents: report from the meeting of the Circulatory System Medical Devices Advisory Panel of the Food and Drug Administration Center for Devices and Radiologic Health, December 7–8, 2006. Circulation 115:2352–2357
Caves JM, Chaikof EL (2006) The evolving impact of microfabrication and nanotechnology on stent design. J Vasc Surg 44:1363–1368
Finkelstein A, McClean D, Kar S et al (2003) Local drug delivery via a coronary stent with programmable release pharmacokinetics. Circulation 107:777–784
Reed ML, Wu C, Kneller J et al (1998) Micromechanical devices for intravascular drug delivery. J Pharm Sci 87:1387–1394
Bhargava B, Reddy NK, Karthikeyan G et al (2006) A novel paclitaxel-eluting porous carbon-carbon nanoparticle coated, nonpolymeric cobalt-chromium stent: evaluation in a porcine model. Catheter Cardiovasc Interv 67:698–702
Guzman LA, Labhasetwar V, Song C et al (1996) Local intraluminal infusion of biodegradable polymeric nanoparticles: a novel approach for prolonged drug delivery after balloon angioplasty. Circulation 94:1441–1448
Kolodgie FD, John M, Khurana C et al (2002) Sustained reduction of in-stent neointimal growth with the use of a novel systemic nanoparticle paclitaxel. Circulation 106:1118–1195
Labhasetwar V, Song C, Humphrey W et al (1998) Arterial uptake of biodegradable nanoparticles: effect of surface modifications. J Pharm Sci 87:1229–1234
Lanza GM, Winter PM, Yu X et al (2002) Targeted antiproliferative drug delivery to vascular smooth muscle cells with a magnetic resonance imaging nanoparticle contrast agent: implications for rational therapy of restenosis. Circulation 106:2842–2847
Winter PM, Morawski AM, Caruthers SD et al (2003) Molecular imaging of angiogenesis in early-stage atherosclerosis with alpha(v)beta3-integrin-targeted nanoparticles. Circulation 108:2270–2274
Winter PM, Neubauer AM, Caruthers SD et al (2006) Endothelial αvβ3 integrin-targeted fumagillin nanoparticles inhibit angiogenesis in atherosclerosis. Arterioscler Thromb Vasc Biol 26:2103–2109
Sprague EA, Pomeranz ML, Odess I et al (2008) Surface material, surface treatment and nanotechnology in cardiovascular stent development. EuroIntervention 4(Suppl C):C60–C62
Lu J, Rao MP, MacDonald NC et al (2008) Improved endothelial cell adhesion and proliferation on patterned titanium surfaces with rationally designed, micrometer to nanometer features. Acta Biomater 4:192–201
Kubo K, Tsukimura N, Iwasa F et al (2009) Cellular behaviour on TiO2 nanonodular structures in a micro-to-nanoscale hierarchy model. Biomaterials 30:5319–5329
Khang D, Lu J, Yao C et al (2008) The role of nanometer and sub-micron surface features on vascular and bone cell adhesion on titanium. Biomaterials 29:970–983
Miller DC, Haberstroh KM, Webster TJ (2005) Mechanism(s) of increased vascular cell adhesion on nanostructured poly(lactic-co-glycolic acid) films. J Biomed Mater Res A 73A:476–484
Miller DC, Thapa A, Haberstroh KM et al (2004) Endothelial and vascular smooth muscle cell function on poly(lactic-co-glycolic acid) with nano-structured surface features. Biomaterials 25:53–61
Liu H, Webster TJ (2006) Nanomedicine for implants: a review of studies and necessary experimental tools. Biomaterials 28:354–369
Aoki J, Serruys PW, van Beusekom H et al (2005) Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth-First In Man) Registry. J Am Coll Cardiol 45:1574–1579
Rotmans JI, Heyligers JM, Verhagen HJ et al (2005) In vivo cell seeding with anti-CD34 antibodies successfully accelerates endothelialization but stimulates intimal hyperplasia in porcine arteriovenous expanded polytetrafluoroethylene grafts. Circulation 112:12–18
Lo CT, Van Tassel PR, Saltzman WM (2009) Simultaneous release of multiple molecules from poly(lactide-co-glycolide) nanoparticles assembled onto medical devices. Biomaterials 30:4889–4897
Krishna OD, Kim K, Byun Y (2005) Covalently grafted phospholipid monolayer on silicone catheter surface for reduction in platelet adhesion. Biomaterials 26:7115–7123
Ellis–Behnke RG, Liang Y, Tay DK et al (2006) Nano hemostat solution: immediate hemostasis at the nanoscale. Nanomedicine 2:207–215
Holland CK, Vaidya SS, Datta S et al (2008) Ultrasound-enhanced tissue plasminogen activator thrombolysis in an in vitro porcine clot model. Thromb Res 121:663–673
Wissgott C, Richter A, Kamusella P et al (2007) Treatment of critcal limb ischaemia using ultrasound enhanced thrombolysis (PARES Trial): final results. J Endovasc Ther 14:433–438
Parikh S, Motarjeme A, McNamara T et al (2008) Ultrasound-accelerated thrombolysis for the treatment of deep venous thrombosis: initial clinical experience. J Vasc Interv Radiol 19:521–528
Alexandrov AV, Molina CA, Grotta JC et al (2004) Ultrasound-enhanced systemic thrombolysis for acute ischaemic stroke. N Engl J Med 351(21):2170–2178
Molina CA, Ribo M, Rubiera M et al (2006) Microbubble administration accelerates clot lysis during continuous 2-MHz ultrasound monitoring in stroke patients treated with intravenous tissue plasminogen activator. Stroke 37:425–429
Culp WC, Porter TR, McCowan TC et al (2003) Microbubble-augmented ultrasound declotting of thrombosed arteriovenous dialysis grafts in dogs. J Vasc Interv Radiol 14:343–347
Laing ST, McPherson DD (2009) Cardiovascular therapeutic uses of targeted ultrasound contrast agents. Cardiovasc Res 83:626–635
Tiukinhoy-Laing SD, Buchanan K, Parikh D et al (2007) Fibrin targeting of tissue plasminogen activator-loaded echogenic liposomes. J Drug Target 15:109–114
Tiukinhoy-Laing SD, Huang S, Klegerman M et al (2007) Ultrasound-facilitated thrombolysis using tissue-plasminogen activator-loaded echogenic liposomes. Thromb Res 119:777–784
Thomas K, Aguar P, Kawasaki H et al (2006) Research strategies for safety evaulation of nanomaterials, part VIII: international efforts to develop risk-based safety evaluations for nanomaterials. Toxicol Sci 92:23–32
Borm PJA, Robbins D, Haubold S et al (2006) The potential risks of nanomaterials: a review carried out for ECETOC. Part Fibre Toxicol 3:11
Curtis J, Greenberg M, Kester J et al (2006) Nanotechnology and nanotoxicology: a primer for clinicians. Toxicol Rev 25:245–260
Lam CW, James JT, McCluskey R et al (2004) Pulmonary toxicity of single walled carbon nanotubes in mice 7 and 90 days after intratracheal instillation. Toxicol Sci 77:126–134
Barillet S, Simon-Deckers A, Herlin-Boime N et al (2010) Toxicological consequences of TiO2, SiC nanoparticles and multi-walled carbon nanotubed exposure in several mammalian cell types: an in vitro study. J Nanopart Res 12:61–73
Wang B, Feng W, Zhu M et al (2009) Neurotoxicity of low-dose repeatedly intranasal instillation of nano- and submicron-sized ferric oxide particles in mice. J Nanopart Res 11:41–53
Villiers CL, Freitas H, Couderc R et al (2010) Analysis of the toxicity of gold nano particles on the immune system: effect on dendritic cell functions. J Nanopart Res 12:55–60
Yu KO, Grabinski CM, Schrand AM et al (2009) Toxicity of amorphous silica nanoparticles in mouse keratinocytes. J Nanopart Res 11:15–24
Freitas RA Jr (2005) Nanotechnology, nanomedicine and nanosurgery. Int J Surg 3:243–246
Mathieu JB, Beaudoin G, Martel S (2006) Method of propulsion of a ferromagnetic core in the cardiovascular system through magnetic gradients generated by an MRI system. IEEE Trans Biomed Eng 53:292–299
Cavalcanti A, Shirinzadeh B, Freitas FA Jr et al (2008) Nanorobot architecture for medical target identification. Nanotechnology 19:015103
Conflict of interest
The authors declare they have no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Power, S., Slattery, M.M. & Lee, M.J. Nanotechnology and its Relationship to Interventional Radiology. Part II: Drug Delivery, Thermotherapy, and Vascular Intervention. Cardiovasc Intervent Radiol 34, 676–690 (2011). https://doi.org/10.1007/s00270-010-9967-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-010-9967-y